Loading clinical trials...

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) | Clinical Trials | Clareo Health

RECRUITINGNCT06029257

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

The main aim of this study is to check the safety and effectiveness of tildrakizumab regarding the alleviation of symptoms in the genital area after administration according to the summary of product ...

Lead sponsor: Almirall, S.A.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Senior Director Regional Medical Affairs

CONTACT

+43 0 15953960 medicalat@almirall.com

Related studies

COMPLETEDPhase 4

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

NCT05969223 · Genital Psoriasis, Scalp Psoriasis

TERMINATEDPhase 4

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

NCT06042920 · Palmoplantar Psoriasis, Genital Psoriasis

COMPLETEDPhase 3

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

NCT02718898 · Genital Psoriasis, Psoriasis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 29, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment110

Start dateNov 2023

Last updatedJan 29, 2025

Condition

Genital Psoriasis

Locations shown

Medizinische Universität Graz

Graz, Styria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions